Sign in

    Charlie [for Mike Zaremski]

    Managing Director and Senior Equity Research Analyst at BMO

    Charlie Zaremski is a Managing Director and Senior Equity Research Analyst at BMO Capital Markets, specializing in insurance sector research with a focus on major U.S. property & casualty and reinsurance companies such as Marsh & McLennan and The Hartford. He has been recognized for his consistent performance in covering these firms, issuing actionable recommendations reflected in ongoing coverage and sector updates. Charlie began his career as an analyst at Berkadia and Faris Lee Investments, later joining JLL as a managing director before taking on his current role at BMO Capital Markets. He holds multiple professional securities licenses and is FINRA-registered, underscoring his expertise in financial analysis and investment strategy.

    Charlie [for Mike Zaremski]'s questions to WILLIS TOWERS WATSON (WTW) leadership

    Charlie [for Mike Zaremski]'s questions to WILLIS TOWERS WATSON (WTW) leadership • Q3 2024

    Question

    Asked about the competitive environment in the London market and its potential impact on the CRB business. Also inquired about the accounting for the TRANZACT business and whether its results would be included in the fourth quarter.

    Answer

    Carl Hess described the global insurance market as stabilizing and softening, but emphasized that WTW's growth is driven by its specialization strategy, not rate trends. Andrew Krasner confirmed that TRANZACT's results are expected to be included for essentially the full year 2024, so the sale won't impact the annual guidance. Its removal will be accretive to growth and margins going forward.

    Ask Fintool Equity Research AI